Petitioner: Duplex Consensus Sequencing Method Not Patentable
ALEXANDRIA, Va. — In a May 6 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, an oncology technology company requests cancellation of a duplex consensus...To view the full article, register now.
Already a subscriber? Click here to view full article